Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome (MDS)

Explore clinical trials studying Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

57 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome (MDS) trial results

Completed

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02920541

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • The Alfred Hospital Melbourne, Australia
  • Royal Melbourne Hospital Parkville, Australia
  • Institut Paoli Calmettes Marseille, France
  • Hôpital Saint Louis Paris, France
View Trial Details
Completed

Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome

NCT01599325

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Peking University People's Hospital Beijing, China
  • The 301 Hospital- Chinese PLA General Hospital Beijing, China
  • The Third Hospital of Peking University Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
View Trial Details
Completed

Darbepoetin Alfa MDS Companion Protocol

NCT02175277

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site Charleroi, Belgium
  • Research Site Leuven, Belgium
  • Research Site Liège, Belgium
  • Research Site Sint-Niklaas, Belgium
View Trial Details
Completed

An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

NCT02238925

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +19 more
Locations
  • Franciscan Saint Francis Health Indianapolis, Indiana, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details

Related conditions